FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...

Applied DNA Sciences shares are trading higher by 18.7% during Tuesday's session. The company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety.

Applied DNA Sciences (APDN) announced that Applied DNA Clinical Labs is repositioning its TR8 PGx pharmacogenomics testing service to offer ...

While the guidelines body still does not explicitly advise oncologists to routinely perform DPYD testing prior to initiating fluoropyrimidine-based chemotherapies like 5-fluorouracil (5-FU) and Xeloda ...

Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8711 ...

For most patients, definitive treatment with combined modality therapy is recommended using concurrent 5-fluorouracil or capecitabine plus mitomycin, with cisplatin as a conditional alternative to ...

Detailed price information for Waverley Pharma Inc (WAVE-X) from The Globe and Mail including charting and trades.

Immune checkpoint inhibitors have shown a survival benefit in patients with metastatic urothelial cancer, so investigators trialed neoadjuvant nivolumab and ipilimumab in patients with muscle-invasive ...

Sales of PBYI's sole-marketed drug, Nerlynx, exceeded management's expectations in fourth-quarter 2024. Also, ongoing studies on alisertib are progressing well.

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo. The conversion to ...